The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease
Open accessAbstract
The composition and spatial organization of the mucosal flora in biopsy specimens from patients with inflammatory bowel disease (IBD; either Crohn's disease or ulcerative colitis), self-limiting colitis, irritable-bowel syndrome (IBS), and healthy controls were investigated by using a broad range of fluorescent bacterial group-specific rRNA-targeted oligonucleotide probes. Each group included 20 subjects. Ten patients who had IBD and who were being treated with antibiotics were also studied. Use of nonaqueous Carnoy fixative to preserve the mucus layer was crucial for detection of bacteria adherent to the mucosal surface (mucosal bacteria). No biofilm was detectable in formalin-fixed biopsy specimens. Mucosal bacteria were found at concentrations greater than 10 9 /ml in 90 to 95% of IBD patients, 95% of patients with self-limiting colitis, 65% of IBS patients, and 35% of healthy controls. The mean density of the mucosal biofilm was 2 powers higher in IBD patients than in patients with IBS or controls, and bacteria were mostly adherent. Bacteroides fragilis was responsible for >60% of the biofilm mass in patients with IBD but for only 30% of the biofilm mass in patients with self-limiting colitis and <15% of the biofilm mass in patients with IBS. In contrast, bacteria which positively hybridized with the probe specific for Eubacterium rectale - Clostridium coccoides accounted for >40% of the biofilm in IBS patients but for <15% of the biofilm in IBD patients. In patients treated with (5-ASA) or antibiotics, the biofilm could be detected with 4,6-diamidino-2-phenylindole but did not hybridize with fluorescence in situ hybridization probes. A Bacteroides fragilis biofilm is the main feature of IBD. This was not previously recognized due to a lack of appropriate tissue fixation. Both 5-ASA and antibiotics suppress but do not eliminate the adherent biofilm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spatial niche partitioning of microbial populations can also be a result of mucus from goblet cells 46 and differential oxygen tolerance47.”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [46]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mr.59.1.143-169.1995 · Cited by 9,218
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Amann, R., Krumholz, L. R., & Stahl, D. A. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.2.762-770.1990 · Cited by 2,207
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Manz, W., Amann, R., Ludwig, W., Wagner, M., & SCHLEIFER, K. H. (1992) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(11)80121-9 · Cited by 2,044
Mucosal flora in inflammatory bowel disease
Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344
Self-citationManz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176
Franks, A. H., Harmsen, H. J. M., Raangs, G. C., Jansen, G. J., Schut, F., & Welling, G. W. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.9.3336-3345.1998 · Cited by 1,056
Langendijk-Genevaux, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M. H. F., & Welling, G. W. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.8.3069-3075.1995 · Cited by 974
Cited by
Sorted by citations
Items 301–400 of 891
Wegmann, U., Louis, P., Goesmann, A., Henrissat, B., Duncan, S. H., & Flint, H. J. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12217 · Cited by 79
“Another important source of heterogeneity derives from the surfaces of the intestinal mucin layer and of digesta particles that provide special microhabitats for microbial colonization (Swidsinski et al., 2005; Walker et al., 2008; Flint et al., 2012b).”
BackgroundSmall bowel bacterial overgrowth: A negative factor in gut adaptation in pediatric SBS
Cole, C. R., & Ziegler, T. R. (2007) · Current Gastroenterology Reports · doi:10.1007/s11894-007-0059-3 · Cited by 80
“Currently, with the use of fluorescent bacterial group– specific rRNA-targeted oligonucleotide probes, bacteria can be identified and quantified on tissue obtained by endoscopic biopsy [ 28 ,29].”
BackgroundRubin, D. T., Cruz-Correa, M. R., Gasché, C., Jass, J. R., Lichtenstein, G. R., Montgomery, E. A., Riddell, R. H., Rutter, M. D., Ullman, T. A., Velayos, F. S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20297 · Cited by 79
Barbara, G., Zecchi, L., Barbaro, M. R., Cremon, C., Bellacosa, L., Marcellini, M. M., GIORGIO, R. D., Corinaldesi, R., & Stanghellini, V. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318264e918 · Cited by 82
Role of colonic microbiota in the pathogenesis of ulcerative colitis
Pei, L.-Y., Ke, Y.-S., Zhao, H., Wang, L., Jia, C., Liu, W., Fu, Q.-H., Shi, M.-N., Cui, J., & Li, S. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0930-3 · Cited by 82
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer
Avril, M., & DePaolo, R. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941710 · Cited by 77
Ritchie, L. E., Sturino, J. M., Carroll, R. J., Rooney, L. W., Azcárate-Peril, M. A., & Turner, N. D. (2015) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiv008 · Cited by 78
“Previous studies have sought to elucidate alterations to the microbiota or identify which bacterial populations might be associated with the onset or recurrence of UC (Loftus 2004; Elson et al. 2005; Swidsinski et al. 2005; Xavier and Podolsky 2007).”
BackgroundRose, D. J., Venema, K., Keshavarzian, A., & Hamaker, B. R. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509993515 · Cited by 78
“For instance, Bacteroides fragilis is found in much larger numbers in the mucosal biofilm in patients with CD compared with healthy individuals, and thus may play a role in the pathogenesis of this disease((50)).”
Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease
Pierre, J. F., Barlow, A. J., Erickson, C. S., Heneghan, A. F., LEVERSON, G. E., Dowd, S. E., Epstein, M. L., Kudsk, K. A., & Gosain, A. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.01.060 · Cited by 73
“coli have been detected at inflammatory mucosal sites and have been implicated in the pathogenesis of Crohn’s disease [44,45].”
BackgroundPurcell, E. B., McKee, R. W., Bordeleau, É., Burrus, V., & Tamayo, R. (2015) · Journal of Bacteriology · doi:10.1128/jb.00816-15 · Cited by 76
Towards a molecular risk map—Recent advances on the etiology of inflammatory bowel disease
Rosenstiel, P. C., Sina, C., Franke, A., & Schreiber, S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.10.001 · Cited by 78
Shiga, H., Kajiura, T., Shinozaki, J., Takagi, S., Kinouchi, Y., Takahashi, S., Negoro, K., Endo, K., Kakuta, Y., Suzuki, M., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.04.014 · Cited by 76
Patrick, S. (2022) · Microbiology · doi:10.1099/mic.0.001156 · Cited by 75
“Bacteroides species biofilms directly adjacent to the mucosal surface may be an indication of abnormality and have been observed in patients with inflammatory bowel disease [21].”
BackgroundBacteria in the pathogenesis of inflammatory bowel disease
Subramanian, S., Campbell, B. J., & Rhodes, J. M. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244054.69253.f3 · Cited by 75
Basso, P. J., Fonseca, M. T., Bonfá, G., Alves, V. B. F., Sales‐Campos, H., Nardini, V., & Cardoso, C. R. D. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143932 · Cited by 75
“5-aminosalicylic acid or some antibiotics can suppress, but not eliminate, bacterial adherent biofilm in patients with IBD (21).”
BackgroundBiofilms of Clostridium species
Pantaleon, V., Bouttier, S., Soavelomandroso, A. P., Janoir, C., & Candela, T. (2014) · Anaerobe · doi:10.1016/j.anaerobe.2014.09.010 · Cited by 74
Alterations in the Intestinal Microbiota and Functional Bowel Symptoms
Ringel, Y., & Carroll, I. M. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.004 · Cited by 73
“compared with that in healthy controls, although the biofilm from IBS biopsies were not as dense as those from IBD patients.(36) Moreover, the predominant bacteria adherent to the intestinal mucosa in IBS patients (the Eubacterium rectale-Clostridium coccoides group) accounted for 48% of the total adherent bacteria co…”
ResultDuncan, K., Carey-Ewend, K., & Vaishnava, S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1874815 · Cited by 79
“studies that associate intestinal biofilms with pathogenic phenotypes such as IBD and colon cancer (13, 46).”
BackgroundIs Crohn’s disease due to defective immunity?
Korzenik, J. R. (2006) · Gut · doi:10.1136/gut.2006.095588 · Cited by 72
Psoriasis and inflammatory bowel disease: links and risks
Bassukas, I. D., Gaitanis, G., Katsanos, K., Christodoulou, D. K., Tsianos, E. V., & Vlachos, C. (2016) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s85194 · Cited by 72
To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis
Yekani, M., Baghi, H. B., Naghili, B., Vahed, S. Z., Sóki, J., & Memar, M. Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104506 · Cited by 71
Hermes, R. G., Molist, F., Pérez, J. F., de Segura, A. G., Ywazaki, M., Davin, R., Nofrarías, M., Korhonen, T., Virkola, R., & Martín-Orúe, S. M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512002978 · Cited by 71
“The FISH technique was performed by modifying the protocol described by Swidsinski et al.(41).”
MethodInfluentialHossain, S., Nisbett, L., & Boon, E. M. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00095 · Cited by 73
Role of Hydrogen Sulfide in Inflammatory Bowel Disease
Stummer, N., Feichtinger, R. G., Weghuber, D., Kofler, B., & Schneider, A.-M. (2023) · Antioxidants · doi:10.3390/antiox12081570 · Cited by 72
Gut Microbial Influences on the Mammalian Intestinal Stem Cell Niche
Peck, B. C. E., Shanahan, M. T., Singh, A. P., & Sethupathy, P. (2017) · Stem Cells International · doi:10.1155/2017/5604727 · Cited by 75
“However, it was not until recently that microbes were visualized deep within crypts [101, 102].”
BackgroundMethodHost responses to mucosal biofilms in the lung and gut
Domingue, J. C., Drewes, J. L., Merlo, C. A., Housseau, F., & Sears, C. L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0270-1 · Cited by 69
Bonfrate, L., Tack, J. F., Grattagliano, I., Cuomo, R., & Portincasa, P. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.799220 · Cited by 69
“Shoepfer et al. [100] investigated antimicrobial and anti-self antibodies in IBS patients compared to IBD patients and controls.”
BackgroundInfluentialAlterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies
Cassmann, E. D., White, R., Atherly, T. A., Wang, C., Sun, Y., Khoda, S., Mosher, C., Ackermann, M. R., & Jergens, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147321 · Cited by 70
“Regarding the effect of formalin fixation [35] on integrity of the intestinal mucus layer (versus Carnoy’s fixative), our experiences using FISH in multiple species suggest that this is not a problem and that the mucus layer remains largely intact even with routine tissue processing.”
BackgroundMethodDifferences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer
Kim, K., Castro, E. J., Shim, H., Advincula, J. V. G., & Kim, Y. W. (2018) · Annals of Coloproctology · doi:10.3393/ac.2018.12.17 · Cited by 68
“Biofilms in CRC patients tend to be thicker and more continuous than those in healthy controls [35, 38].”
BackgroundWoldeamlak, B., Yirdaw, K., & Biadgo, B. (2019) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.74.6.314 · Cited by 67
Dassanayake, R. P., Falkenberg, S. M., Stasko, J. B., Shircliff, A. L., Lippolis, J. D., & Briggs, R. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233973 · Cited by 66
“Carnoy’s fixative solution (ethanol/chloroform/acetic acid-6:3:1) has been commonly used to preserve mucus since fixation with formalin often causes the loss of mucus layers [36, 37].”
BackgroundMethodInfluentialKhalil, N. A., Walton, G., Gibson, G. R., Tuohy, K. M., & Andrews, S. C. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.825700 · Cited by 66
“Other work has revealed far higher levels of bacteria colonising the mucosa within the bowel of UC patients (Swidsinski et al., 2005), with 100-fold increases in mean densities of mucosal biofilms.”
BackgroundBugging inflammation: role of the gut microbiota
Shen, S., & Wong, C. H. Y. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.12 · Cited by 67
Zhang, P., Mao, D., Gao, H., Zheng, L., Chen, Z., Gao, Y., Duan, Y., Guo, J., Luo, Y., & Ren, H. (2021) · The ISME Journal · doi:10.1038/s41396-021-01171-x · Cited by 65
“Increased bacterial biofilm might have facilitated the evolved strains into the mucus layer of the murine intestine tract [58].”
BackgroundGut microbiota: a non-target victim of pesticide-induced toxicity
Sharma, T., Natesh, N. S., Pothuraju, R., Batra, S. K., & Rachagani, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2187578 · Cited by 68
Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz: Figure 1
Kummer, O., Mossdorf, E., Battegay, M., Elzi, L., Bodmer, M., Krähenbühl, S., & Haschke, M. (2007) · Gut · doi:10.1136/gut.2007.126144 · Cited by 63
Identification and Visualization of a Distinct Microbiome in Ocular Surface Conjunctival Tissue
Ozkan, J., Coroneo, M. T., Willcox, M. D. P., Wemheuer, B., & Thomas, T. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24651 · Cited by 66
Harris, K. G., & Chang, E. B. (2018) · Clinical Science · doi:10.1042/cs20171110 · Cited by 66
“Many independent studies have shown that microbes are more likely to penetrate the mucus layer and are found closer to the intestinal epithelium in IBD patients than in healthy controls (22, 71, 72).”
BackgroundFeline gastrointestinal microbiota
Minamoto, Y., Hooda, S., Swanson, K. S., & Suchodolski, J. S. (2012) · Animal Health Research Reviews · doi:10.1017/s1466252312000060 · Cited by 72
“It can also add information about the morphology and the spatial distribution of the organism (Amann et al., 1995; Moter and Göbel, 2000; Zoetendal et al., 2004; Swidsinski et al., 2005).”
BackgroundRules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
Jergens, A. E., Parvinroo, S., Kopper, J., & Wannemuehler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.669913 · Cited by 63
Modulating the Microbiome for Crohn’s Disease Treatment
Gowen, R., Gamal, A., Martino, L. D., McCormick, T. S., & Ghannoum, M. A. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.017 · Cited by 70
The role of animal hosts in shaping gut microbiome variation
Maritan, E., Quagliariello, A., Frago, E., Patarnello, T., & Martino, M. E. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0071 · Cited by 67
Bacterial Flora in Inflammatory Bowel Disease
Marteau, P. R. (2009) · Digestive Diseases · doi:10.1159/000268128 · Cited by 63
“One should keep in mind that the ecological conditions vary between niches in the gastrointestinal tract and this explains why their inhabitants differ. The luminal flora differs between the stomach, upper small bowel, lower small bowel, right colon and rectum. It also differs from the mucosal flora at each site, whic…”
BackgroundGeisel, J., Kahl, F., Müller, M., Wagner, H., Kirschning, C. J., Autenrieth, I. B., & Frick, J.-S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5811 · Cited by 64
“In contrast, in a state of chronic disease the microbiota might overcome a reduced mucus layer (39), leading to activation and maturation of DC, which provide a proinflammatory cytokine response, trigger T cell proliferation and an inflammatory host reaction before shading off into a maturation dependent, IL-6 indepen…”
BackgroundPhalak, P., Chen, J., Carlson, R. P., & Henson, M. A. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0334-8 · Cited by 64
“For example, the human gut microbiome has emerged as a major focus for biomedical research with mounting evidence suggesting unhealthy gut flora biofilms are associated with illnesses including autoimmune diseases, colorectal cancer and inflammatory bowel disease [5–10].”
BackgroundActive thrombin produced by the intestinal epithelium controls mucosal biofilms
Motta, J., Denadai‐Souza, A., Sagnat, D., Guiraud, L., Edir, A., Bonnart, C., Sebbag, M., Rousset, P., Lapeyre, A., Séguy, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11140-w · Cited by 63
Intestinal Staphylococcus spp. and virulent features associated with coeliac disease
Sánchez, E., Ribes‐Koninckx, C., Calabuig, M., & Sanz, Y. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200759 · Cited by 62
“In fact, biofilm formation is a common colonisation mechanism of both commensal and pathogenic bacteria, facilitating their persistence in different environments, including the gastrointestinal tract35 36; this phenomenon has also been related to microbial alterations in IBDs.37 Our study also reports there is an incr…”
BackgroundImaging biofilms using fluorescence in situ hybridization: seeing is believing
BARBOSA, A. B. D. O., Miranda, S., Azevedo, N. F., Cerqueira, L., & Azevedo, A. S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1195803 · Cited by 67
“As mentioned in previous sections, several FISH variants provide important phylogenetic information in complex and heterogeneous biofilms (Swidsinski et al., 2005).”
BackgroundThe Relationship of Candida albicans with the Oral Bacterial Microbiome in Health and Disease
Bertolini, M., & Dongari‐Bagtzoglou, A. I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28524-1_6 · Cited by 65
Vasquez, N., Mangin, I., Lepage, P., Seksik, P., Huyen, J. D. V., Blum, S., Schiffrin, E. J., Suau, A., Allez, M., Vernier, G., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20084 · Cited by 61
Biofilm tolerance, resistance and infections increasing threat of public health
Yang, S., Li, X., Cang, W., Mu, D., Ji, S., An, Y., Wu, R., & Wu, J. (2023) · Microbial Cell · doi:10.15698/mic2023.11.807 · Cited by 81
“However, it is generally believed that intestinal flora has beneficial and adverse effects on these diseases [93, 94].”
The Microbiota in Inflammatory Bowel Disease in Different Age Groups
Cucchiara, S., Iebba, V., Conte, M. P., & Schippa, S. (2009) · Digestive Diseases · doi:10.1159/000228558 · Cited by 61
RetractedFrick, J.-S., Fink, K., Kahl, F., Niemiec, M. J., Quitadamo, M., Schenk, K., & Autenrieth, I. B. (2007) · Infection and Immunity · doi:10.1128/iai.00119-07 · Cited by 60
“Studies investigating the spatial distribution of the mucosal microbiota in humans revealed adherent commensals in patients with inflammatory bowel disease when compared to healthy controls (43).”
BackgroundImmunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 60
Leatham-Jensen, M. P., Frimodt-Møller, J., Adediran, J., Mokszycki, M. E., Banner, M., Caughron, J. E., Krogfelt, K. A., Conway, T., & Cohen, P. S. (2012) · Infection and Immunity · doi:10.1128/iai.06193-11 · Cited by 62
“It has recently become clear that biofilms form in the mucus layers of the large intestines of humans, rats, baboons, and mice (49, 61) and that mixed biofilms consisting of bacteroides, enterobacter, and clostridium species form rapidly on strands of mucin in mucus introduced into a growing human microbiota contained…”
BackgroundTsuruya, A., Kuwahara, A., Saito, Y., Yamaguchi, H., Tenma, N., Inai, M., Takahashi, S., Tsutsumi, E., Suwa, Y., Totsuka, Y., et al. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv135 · Cited by 59
“Finally, it is noteworthy that the association of lactic acid bacteriawith the colorectal mucosawas previously shown (Swidsinski et al., 2002, 2005;Vesterlund et al., 2005;Macfarlane andDillon, 2007; Chen et al., 2012) and some of these bacteria could serve as PAAs (Fig.”
BackgroundMethodInfluentialEcological Characterization of the Colonic Microbiota of Normal and Diarrheic Dogs
Bell, J. A., Kopper, J. J., Turnbull, J. A., Barbu, N. I., Murphy, A. J., & Mansfield, L. S. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/149694 · Cited by 58
“It is acknowledged that further work will be needed to document the ability of readily available fecal samples to represent different locations within the colon to document the etiologies of these diarrheas [64].”
BackgroundThompson, A., Meah, D., Ahmed, N., Conniff-Jenkins, R., Chileshe, E., Phillips, C., Claypole, T. C., Forman, D. W., & Row, P. E. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-338 · Cited by 58
“coli was found to be more prevalent in the mucosal microbiota of IBS patients than those of healthy control subjects when biopsy specimens were labelled with fluorescent in situ hybridisation probes [28], and enteroaggregative strains of E.”
BackgroundSeksik, P. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70020-8 · Cited by 60
Walujkar, S. A., Kumbhare, S. V., Marathe, N. P., Patangia, D. V., Lawate, P. S., Bharadwaj, R. S., & Shouche, Y. S. (2018) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-018-2449-0 · Cited by 57
“increase in the abundance of abnormal bacterial communities including Stenotrophomonas, Ochrobactrum, Achromobacter may have an adverse impact on the gut health, which may further be responsible for the alteration of immune response and causation of chronic state of UC (Hellmig et al. 2005; Swidsinski et al. 2005; Knö…”
BackgroundPai, Y.-C., Li, Y.-H., Turner, J. R., & Yu, L. C. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad064 · Cited by 59
“Elevated intestinal permeability, before either disease onset or symptom flare, 1–3 increased numbers of mucosa-associated bacteria, 4,5 and altered microbiota composition 6,7 have been described in IBD patients.”
BackgroundMethodAntimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
Kim, J. M. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.1.20 · Cited by 57
“Moreover, SLPI has anti-microbial activity against Salmonella Typhimurium.67 Some studies have reported that protease inhibitors are profoundly associated with the incidence of IBD.”
BackgroundInfluentialSwidsinski, A. V., Dörffel, Y., Loening-Baucke, V. A., Tertychnyy, A. S., Biche-Ool, S. K., Стоногин, С. В., Guo, Y., & Sun, N.-D. (2012) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.91734 · Cited by 55
“Multicolor FISH was performed according to previously described protocols for evaluation of tissue specimens and identification of bacteria[3,4] with a Nikon e600 fluorescence microscope (Nikon, Tokyo, Japan) and Nikon DXM1200 camera.”
MethodSelf-citationThe human intestinal microbiota
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70015-4 · Cited by 67
Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
Marônek, M., Link, R., Ambro, Ľ., & Gardlík, R. (2020) · Cells · doi:10.3390/cells9041013 · Cited by 54
“To date, studies fail to provide a definite answer, as some suggested that no differences exist between ulcerated and non-ulcerated mucosa [26] while others showed less bacteria in ulcerated mucosa [27].”
BackgroundSafety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model
Titécat, M., Rousseaux, C., Dubuquoy, C., Foligné, B., Rahmouni, O., Mahieux, S., Desreumaux, P., Woolston, J., Sulakvelidze, A., Wannerberger, K., et al. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac064 · Cited by 60
Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
Kang, D.-Y., Park, J., Yeo, M., Kang, S., Kim, J., Kim, J., & Kim, S. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03084-5 · Cited by 54
Mondragón-Palomino, O., Poceviciute, R., Lignell, A., Griffiths, J. A., Takko, H., & Ismagilov, R. F. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118483119 · Cited by 54
Wood, A. J., Fraser, J. D., Swift, S., Patterson-Emanuelson, E. A. C., Amirapu, S., & Douglas, R. G. (2012) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2012.26.3779 · Cited by 53
Wu, M.-C., Chen, Y.-C., Lin, T., Hsieh, P., & Wang, J. (2012) · Infection and Immunity · doi:10.1128/iai.06247-11 · Cited by 53
“Bacteria colonize and extensively establish biofilms that cover mucosal surfaces in the gastrointestinal tract (30, 43).”
BackgroundBakır-Güngör, B., Hacılar, H., Jabeer, A., Nalbantoğlu, Ö. U., Aran, O., & Yousef, M. (2022) · PeerJ · doi:10.7717/peerj.13205 · Cited by 57
“Swidsinski et al indicated that the levels of Ruminococcus bromii have changed in IBD patients (Swidsinski et al., 2005).”
BackgroundTelling the whole story in a 10,000-genome world
Beiko, R. G. (2011) · Biology Direct · doi:10.1186/1745-6150-6-34 · Cited by 52
“Representatives of both groups are found together in some habitats such as in adhering to the intestinal mucosa of patients with irritable bowel syndrome [74], suggesting an opportunity for habitat-directed LGT.”
BackgroundNuding, S., Zabel, L. T., Enders, C., Porter, E. M., Fellermann, K., Wehkamp, J., Mueller, H. A. G., & Stange, E. F. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.01.001 · Cited by 52
“Therefore, this would prevent overgrowth in the mucus which is known to be poor in bacteria while maintaining the luminal flora [34].”
Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis
Swidsinski, A. V., Loening-Baucke, V. A., Bengmark, S., Lochs, H. H., & Dörffel, Y. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20003 · Cited by 52
Self-citationCollado, M. C., & Sanz, Y. (2006) · Veterinary Microbiology · doi:10.1016/j.vetmic.2006.12.006 · Cited by 52
The domain Archaea in human mucosal surfaces
Matarazzo, F., Ribeiro, A. C., Faveri, M., Taddei, C. R., Martinez, M. B., & Mayer, M. P. A. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03958.x · Cited by 54
“ticular pathogen, but rather with a microbial shift towards an anaerobic consortium, consisting of saccharolytic and proteolytic strictly anaerobic bacteria, including Clostridium, Eubacterium, the Bacteroides/Prevotella cluster [65,66], the terminal-degrading methanogens [13,62], and SRB [65], with a concomitant redu…”
BackgroundSauvaitre, T., Etienne‐Mesmin, L., Sivignon, A., Mosoni, P., Courtin, C. M., de Wiele, T. V., & Blanquet‐Diot, S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa052 · Cited by 53
Lin, X., Zhao, J., Zhang, W., He, L., Wang, L., Li, H., Liu, Q., Cui, L., Gao, Y., Chen, C., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124923 · Cited by 52
Pai, Y.-C., Weng, L.-T., Wei, S., Wu, L., Shih, D. Q., Targan, S. R., Turner, J. R., & Yu, L. C. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa165 · Cited by 51
Protective Effect of Tuna Bioactive Peptide on Dextran Sulfate Sodium-Induced Colitis in Mice
Xiang, X., Zhou, X., Wang, R., Shu, C.-H., Zhou, Y.-F., Ying, X., & Zheng, B. (2021) · Marine Drugs · doi:10.3390/md19030127 · Cited by 54
“These include reduced gut ability to resist invasion by foreign pathogens, damage to intestinal tissues, and an aberrant immune response [6,7].”
BackgroundImplications of Gut Microbiota in Complex Human Diseases
Yu, D., Meng, X., de Vos, W. M., Wu, H., Fang, X., & Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312661 · Cited by 51
“Microscopic results showed that patients with IBD had dense Bacteroides fragilis biofilms [167].”
BackgroundWang, Y., Antonopoulos, D. A., Zhu, X., Harrell, L. E., Hanan, I. M., Alverdy, J. C., Meyer, F., Musch, M. W., Young, V. B., & Chang, E. B. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2921-8 · Cited by 51
“Perturbations in the gut microbiota may be associated with several human diseases, particularly inflammatory bowel diseases which often affect mucosal inflammation in a regional as well as a spatially dependent manner ( Swidsinski et al.2005, 2002 ).”
BackgroundFrolová, L., Smetana, K., Borovská, D., Kitanovičová, A., Kostovcikova, K., Janatková, I., Malíčková, K., Lukáš, M., Drastich, P., Beneš, Z., et al. (2009) · Inflammation Research · doi:10.1007/s00011-009-0016-8 · Cited by 51
“factor in pathogenetic mechanisms of IBD [37–41].”
Bábíčková, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11321 · Cited by 52
N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli
Sicard, J.-F., Vogeleer, P., Bihan, G. L., Olivera, Y. R., Beaudry, F., Jacques, M., & Harel, J. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0252-y · Cited by 51
Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10−/− Mice
Ye, J., Lee, J. W., Presley, L. L., Bent, E., Wei, B., Braun, J. G., Schiller, N. L., Straus, D. S., & Borneman, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20442 · Cited by 51
Gut biofilms:Bacteroidesas model symbionts to study biofilm formation by intestinal anaerobes
Béchon, N., & Ghigo, J. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab054 · Cited by 54
Dissecting Gut‐Microbial Community Interactions using a Gut Microbiome‐on‐a‐Chip
Lee, J., Menon, N. V., & Lim, C. T. (2024) · Advanced Science · doi:10.1002/advs.202302113 · Cited by 50
Damianos, J., Abdelnaem, N., & Camilleri, M. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.09.007 · Cited by 54
Motta, J., Allain, T., Green-Harrison, L. E., Groves, R. A., Feener, T. D., Ramay, H. R., Beck, P. L., Lewis, I. A., Wallace, J. L., & Buret, A. G. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy116 · Cited by 50
Okubo, R., Kinoshita, T., Katsumata, N., Uezono, Y., Xiao, J., & Matsuoka, Y. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.025 · Cited by 51
FISH analysis of Lactobacillus biofilms in the gastrointestinal tract of different hosts
Lebeer, S., Verhoeven, T. L. A., Claes, I. J. J., Hertogh, G., Vermeire, S., Buyse, J., Immerseel, F. V., Vanderleyden, J., & Keersmaecker, S. C. J. D. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02994.x · Cited by 49
“In agreement with previous studies (Macfarlane et al. 2004; Swidsinski et al. 2005), the spatial organization of the endogenous microbiota was not preserved in formalin-fixed tissues.”
BackgroundResultInfluentialBacterial biofilms as a potential contributor to mucinous colorectal cancer formation
Li, S., Peppelenbosch, M. P., & Smits, R. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.009 · Cited by 49
Optimal sampling of the intestinal microbiota for research
Sartor, R. B. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.46 · Cited by 48
Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure
Ziegler, T. R., & Cole, C. R. (2007) · Current Gastroenterology Reports · doi:10.1007/s11894-007-0060-x · Cited by 48
“Fluorescent bacterial group-specific rRNA-targeted oligonucleotide probes can be used to identify and quantitate bacteria on tissue obtained by biopsy, but this is not a standard clinical approach to diagnosis [ 33 ].”
BackgroundEun, C. S., Kwak, M.-J., Han, D. S., Lee, A. R., Park, D. I., Yang, S., Kim, Y. S., & Kim, J. F. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0437-0 · Cited by 48
“coli and other numerous bacteria are increased in the mucosa of inflammatory bowel diseases (IBD) patients [24, 25].”
BackgroundThe Role of Fecal Microbiota Transplantation in IBD
Fanizzi, F., D’Amico, F., Bombassaro, I., Zilli, A., Furfaro, F., Parigi, T. L., Cicerone, C., Fiorino, G., Peyrin‐Biroulet, L., Danese, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12091755 · Cited by 49
“Bacteroides fragilis is another potential pathobiont, found abundantly in IBD patients’ biofilms and able to persist in harsh conditions [33].”
Changes in Gut Microbiota May Be Early Signs of Liver Toxicity Induced by Epoxiconazole in Rats
Xu, C. Y., Liu, Q., Huan, F., Qu, J., Liu, W., Gu, A., Wang, Y., & Jiang, Z. (2014) · Chemotherapy · doi:10.1159/000371837 · Cited by 47
Tochio, T., Kitaura, Y., Nakamura, S., Sugawa, C., Takahashi, M., Endo, A., & Shimomura, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166850 · Cited by 47
Smith, S. C., Chalker, A., Dewar, M., & Arnould, J. P. Y. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12157 · Cited by 46
Metadata
- Authors
- Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Duke Medical Center (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2005-07
- Volume
- 43
- Issue
- 7
- Pages
- 3380-3389
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1169142
- OpenAlex
- W2097177097
- Cited by
- 894
- References
- 36
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 45 · 2023: 47 · 2022: 59 · 2021: 47 · 2020: 50 · 2019: 54 · 2018: 46 · 2017: 35 · 2016: 47 · 2015: 49 · 2014: 41 · 2013: 43 · 2012: 44
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli and Edythe Broad Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, Bacteroides fragilis, irritable bowel syndrome, 5-aminosalicylic acid, antibiotic therapy, bacterial adhesion, fluorescence in situ hybridization, rRNA-targeted oligonucleotide probes
- MeSH terms
- Adult, Bacteria, Bacteroides fragilis, Biopsy, Colitis, Ulcerative, Crohn Disease, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Colon, Sigmoid, In Situ Hybridization, Fluorescence, Ecosystem, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review